ASH 2020: Updated Results from the Murano Five-Year Analysis in R/R CLL
Results From the Phase 2 CAPTIVATE Study
ASH 2020: Results From the UNITY-CLL Study of Ublituximab Doublet Versus Chemoimmunotherapy in CLL
ASH 2020: TRANSCEND-CLL-004 Study: Results of CAR-T Monotherapy in R/R CLL or SLL
ASH 2020: TRANSCEND-CLL-004 Study: Results of CAR-T Combination in R/R CLL or SLL
ASH 2020: Results From the Phase 1/2 BRUIN Trial
